Fund+

VC · (Belgium)

VC

Seed

Series A

Hardware

Healthcare

Sign up free to access full profile and submit your pitch.

About

Fund+ is an open-ended Fund for long term equity investment in innovative Life Sciences companies with a focus on Belgium. We want to create sustainable shareholders value, contribute to the development of a leadership position in the Life Sciences sector and generate a tangible, beneficial societal impact.

Investment Criteria

Other investors that have backed the same portfolio companies as Fund+. Expand any entry to see the shared portfolio companies.

• Sambrinvest S.A.

  6 shared

  Shared portfolio companies

  • Cellaïon SA/NV
  • EPICS Therapeutics SA
  • ExeVir Bio BV
  • Iteos Therapeutics S.A.
  • Minoryx Therapeutics s.l.
  • PROMETHERA Biosciences S.A./N.V.
• EQT Holdings AB

  4 shared

  Shared portfolio companies

  • Egle Therapeutics SAS
  • eTheRNA immunotherapies NV
  • Immunic, Inc.
  • Tubulis GmbH
• PMV

  4 shared

  Shared portfolio companies

  • Aelin Therapeutics NV
  • Confo Therapeutics
  • eTheRNA immunotherapies NV
  • Indigo Diabetes nv
• V-Bio Ventures

  4 shared

  Shared portfolio companies

  • AstriVax NV
  • Coave Therapeutics
  • Confo Therapeutics
  • ExeVir Bio BV
• BNP Paribas Fortis Private Equity Expansion NV

  3 shared

  Shared portfolio companies

  • AstriVax NV
  • EPICS Therapeutics SA
  • eTheRNA immunotherapies NV
• Invest.BW

  3 shared

  Shared portfolio companies

  • Cellaïon SA/NV
  • Novadip Biosciences SA
  • PROMETHERA Biosciences S.A./N.V.
• Invus

  3 shared

  Shared portfolio companies

  • Coave Therapeutics
  • Immunic, Inc.
  • Iteos Therapeutics S.A.
• Andera Partners

  2 shared

  Shared portfolio companies

  • TargED Biopharmaceuticals B.V.
  • Tubulis GmbH
• Bayern Kapital

  2 shared

  Shared portfolio companies

  • Immunic, Inc.
  • Tubulis GmbH
• BioGeneration Ventures

  2 shared

  Shared portfolio companies

  • Confo Therapeutics
  • TargED Biopharmaceuticals B.V.